175 related articles for article (PubMed ID: 11273534)
1. Effects of cyclo-oxygenase and thromboxane synthetase inhibitors on right atrial prostaglandins.
Madan ZM; Sainani GS
J Assoc Physicians India; 2000 Jun; 48(6):581-3. PubMed ID: 11273534
[TBL] [Abstract][Full Text] [Related]
2. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
[TBL] [Abstract][Full Text] [Related]
3. Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.
Hardee MM; Moore JN; Hardee GE
Res Vet Sci; 1986 Mar; 40(2):152-6. PubMed ID: 3517992
[TBL] [Abstract][Full Text] [Related]
4. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids.
Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):95-103. PubMed ID: 11237476
[TBL] [Abstract][Full Text] [Related]
5. Reduction of urinary 8-epi-prostaglandin F2 alpha during cyclo-oxygenase inhibition in rats but not in man.
Bachi A; Brambilla R; Fanelli R; Bianchi R; Zuccato E; Chiabrando C
Br J Pharmacol; 1997 Aug; 121(8):1770-4. PubMed ID: 9283716
[TBL] [Abstract][Full Text] [Related]
6. Systemic and regional hemodynamic effects of cyclo-oxygenase and thromboxane synthetase inhibition in normal and hyperdynamic endotoxemic rabbits.
Fink MP; Morrissey PE; Stein KL; Clement RE; Fiallo V; Gardiner WM
Circ Shock; 1988 Sep; 26(1):41-57. PubMed ID: 3142697
[TBL] [Abstract][Full Text] [Related]
7. Prostacyclin and thromboxane A2 synthesis by rabbit pulmonary artery.
Salzman PM; Salmon JA; Moncada S
J Pharmacol Exp Ther; 1980 Oct; 215(1):240-7. PubMed ID: 7005425
[TBL] [Abstract][Full Text] [Related]
8. Thromboxane and prostacyclin changes during cardiopulmonary bypass with and without pulsatile flow.
Watkins WD; Peterson MB; Kong DL; Kono K; Buckley MJ; Levine FH; Philbin DM
J Thorac Cardiovasc Surg; 1982 Aug; 84(2):250-6. PubMed ID: 6980332
[TBL] [Abstract][Full Text] [Related]
9. Thromboxane and prostacyclin production during septic shock.
Butler RR; Wise WC; Halushka PV; Cook JA
Adv Shock Res; 1982; 7():133-45. PubMed ID: 6753528
[TBL] [Abstract][Full Text] [Related]
10. Differential inhibition of platelet thromboxane and lung prostacyclin production by sulphinpyrazone, acetylsalicylic acid and indomethacin by human tissues in vitro.
Toivanen J; Ylikorkala O; Viinikka L
Thromb Res; 1985 Feb; 37(4):493-502. PubMed ID: 3920778
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandins and prostaglandin synthetase inhibitors regulate the synthesis of complement components by human monocytes.
Lappin DF; Whaley K
Clin Exp Immunol; 1982 Sep; 49(3):623-30. PubMed ID: 6816495
[TBL] [Abstract][Full Text] [Related]
12. Effects of dl-3-n-butylphthalide on production of TXB2 and 6-keto-PGF1 alpha in rat brain during focal cerebral ischemia and reperfusion.
Chong ZZ; Feng YP
Zhongguo Yao Li Xue Bao; 1997 Nov; 18(6):505-8. PubMed ID: 10322905
[TBL] [Abstract][Full Text] [Related]
13. Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904.
Yoshida T; Ichikawa Y; Tojo T; Homma M
Lupus; 1996 Apr; 5(2):129-38. PubMed ID: 8743126
[TBL] [Abstract][Full Text] [Related]
14. Implications for thromboxane A2 in the pathogenesis of endotoxic shock.
Wise WC; Cook JA; Halushka PV
Adv Shock Res; 1981; 6():83-91. PubMed ID: 6961767
[TBL] [Abstract][Full Text] [Related]
15. Roles of endogenous prostacyclin and thromboxane A2 in the ischemic canine heart.
Sakai K; Ito K; Ogawa K
J Cardiovasc Pharmacol; 1982; 4(1):129-35. PubMed ID: 6176788
[TBL] [Abstract][Full Text] [Related]
16. Effect of aspirin treatment on plasma levels of keto PGF 1 alpha and thromboxane B2.
Madan ZM; Sainani GS
J Assoc Physicians India; 1995 Sep; 43(9):597-9. PubMed ID: 8773058
[TBL] [Abstract][Full Text] [Related]
17. A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2.
Defreyn G; Deckmyn H; Vermylen J
Thromb Res; 1982 Jun; 26(6):389-400. PubMed ID: 7051416
[TBL] [Abstract][Full Text] [Related]
18. Stretch-induced contraction of rabbit isolated pulmonary artery and the involvement of endothelium-derived thromboxane A2.
Nakayama K; Ueta K; Tanaka Y; Tanabe Y; Ishii K
Br J Pharmacol; 1997 Sep; 122(2):199-208. PubMed ID: 9313926
[TBL] [Abstract][Full Text] [Related]
19. Endothelium-dependent contractions in rabbit pulmonary artery are mediated by thromboxane A2.
Buzzard CJ; Pfister SL; Campbell WB
Circ Res; 1993 May; 72(5):1023-34. PubMed ID: 8477518
[TBL] [Abstract][Full Text] [Related]
20. Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis.
Aiken JW; Shebuski RJ; Miller OV; Gorman RR
J Pharmacol Exp Ther; 1981 Nov; 219(2):299-308. PubMed ID: 6270303
[No Abstract] [Full Text] [Related]
[Next] [New Search]
